세계의 HLA 타이핑 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for HLA Typing Market is presumed to reach the market size of nearly USD 14.11 Million by 2032 from USD 5.75 Million in 2023 with a CAGR of 10.5% under the study period 2024 - 2032.

HLA typing, or human leukocyte antigen typing, is a process used to identify specific proteins on the surface of cells that are crucial in the immune system's ability to recognize foreign substances. These proteins, encoded by genes within the major histocompatibility complex (MHC), help the immune system distinguish between self and non-self cells. It is important in various medical contexts, including organ transplantation, where matching the HLA profiles of donors and recipients reduces rejection risks. It is also used in blood transfusions and disease association studies, aiding in the diagnosis and treatment of autoimmune diseases and certain cancers.

MARKET DYNAMICS

The HLA typing market is being propelled by several key factors shaping the landscape of medical diagnostics and transplantation medicine. The increasing prevalence of autoimmune diseases, infectious diseases, and hematological malignancies necessitates accurate and reliable HLA typing for disease diagnosis, prognosis, and treatment selection. Additionally, the rising demand for organ and tissue transplantation, driven by the growing aging population and the prevalence of chronic diseases, fuels the need for this process to match donors and recipients and minimize the risk of rejection. Moreover, advancements in HLA typing technologies, such as NGS, polymerase chain reaction, and sequence-specific oligonucleotide probes (SSOP), enhance the accuracy, speed, and scalability of these assays, enabling high-resolution typing and allele identification. Furthermore, its integration into routine clinical practice and transplant management protocols, supported by clinical guidelines and regulatory standards, drives the adoption and utilization of typing services in healthcare settings worldwide. Additionally, increasing investments in research and development to expand its applications in personalized medicine, pharmacogenomics, and immune profiling contribute to market growth and innovation in this technology and service. Furthermore, strategic collaborations and partnerships among healthcare organizations, diagnostic laboratories, and technology providers facilitate the development and commercialization of novel HLA typing solutions and expand market reach. However, stringent regulatory requirements and the complexity of the procedures may hinder the growth of this market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of HLA typing. The growth and trends of HLA typing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the hla typing market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Instruments
• Reagents & Consumables
• Software & Services

By Application

• Diagnosis
• Research

By Technique

• Molecular Assay
• Sequenced-Based Molecular Assay
• Non-Molecular Assay

By End-User

• Commercial Service Providers
• Hospitals And Transplant Centers
• Research Labs & Academic Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the HLA Typing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the HLA typing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, Pacific Biosciences. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . HLA TYPING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Technique
  • 3.7.4 Market Attractiveness Analysis By End-User
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL HLA TYPING MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Instruments Historic and Forecast Sales by Regions
• 5.5 Reagents & Consumables Historic and Forecast Sales by Regions
• 5.6 Software & Services Historic and Forecast Sales by Regions

6 . GLOBAL HLA TYPING MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Diagnosis Historic and Forecast Sales by Regions
• 6.5 Research Historic and Forecast Sales by Regions

7 . GLOBAL HLA TYPING MARKET ANALYSIS BY TECHNIQUE

• 7.1 Overview by Technique
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Technique
• 7.4 Molecular Assay Historic and Forecast Sales by Regions
• 7.5 Sequenced-Based Molecular Assay Historic and Forecast Sales by Regions
• 7.6 Non-Molecular Assay Historic and Forecast Sales by Regions

8 . GLOBAL HLA TYPING MARKET ANALYSIS BY END-USER

• 8.1 Overview by End-User
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-User
• 8.4 Commercial Service Providers Historic and Forecast Sales by Regions
• 8.5 Hospitals And Transplant Centers Historic and Forecast Sales by Regions
• 8.6 Research Labs & Academic Institutes Historic and Forecast Sales by Regions

9 . GLOBAL HLA TYPING MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HLA TYPING COMPANIES

• 10.1. Hla Typing Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF HLA TYPING INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Thermo Fisher Scientific Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Bio-Rad Laboratories Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Qiagen N.V.
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Omixon Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. GenDx
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Illumina Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. TBG Diagnostics Limited
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Dickinson and Company
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Takara Bio Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. F. Hoffman-La Roche Limited
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments
• 11.13. Pacific Biosciences
  • 11.13.1. Company Overview
  • 11.13.2. Company Revenue
  • 11.13.3. Products
  • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies